Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update

Go back to Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update

Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 2c

May 10, 2021 5:31 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $30.2 million versus the consensus estimate of $32.1 million.

For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.

... More